Perioperative hemostasis is crucial during surgeries, particularly mitral valve replacements. Patients with coagulation disorders face higher bleeding risks, making careful management essential.

In a notable case, a 47-year-old woman with hypoprothrombinemia underwent successful mitral valve replacement.

Hypoprothrombinemia, linked to lupus anticoagulant, complicates surgical procedures like mitral valve replacement.

The surgical team utilized comprehensive coagulation studies and initiated bridging therapy with low molecular weight heparin (LMWH).

Teamwork among cardiologists, hematologists, and surgeons is crucial in managing complex cases.

Advancements in diagnostic tools and research into genetic markers promise more personalized anticoagulation strategies.

The successful management of hemostasis in challenging cases highlights the evolution of surgical practices. Ongoing research and interdisciplinary collaboration will continue to enhance outcomes for patients facing complex coagulation disorders.